BCIQ Profiles

Company Profile ReportTarget Profile Report

MAP3K7, IL18R1 as targets in obesity-related cerebrovascular dysfunction

DISEASE CATEGORY: Endocrine/metabolic; neurology

INDICATION: Obesity; stroke

Inhibiting MAP3K7 or the IL-18 receptor subunit IL18R1 could treat obesity-associated cerebrovascular dysfunction. In

Read the full 194 word article

How to gain access

Continue reading with a
two-week free trial.